Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin G Liu

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulatorsHermogenes N Jimenez, Kevin G Liu, Sang-Phyo Hong, et al.
Journal of Medicinal Chemistry|April 14, 2020
Discovery and Optimization of Glucose Uptake InhibitorsKevin G Liu, Ji-In Kim, Kellen Olszewski, et al.
World Neurosurgery|July 27, 2024
Lumbar Fusions in Patients with Sickle Cell Disease: A Propensity-Matched Analysis of Postoperative ComplicationsKevin G Liu, Andy T Ton, Michael Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2009
Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2009
1-Sulfonylindazoles as potent and selective 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2009
Identification of a series of benzoxazoles as potent 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2008
A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Cell Chemical Biology|October 29, 2021
Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumorsKellen Olszewski, Anthony Barsotti, Xiao-Jiang Feng, et al.
Journal of Neurosurgery|January 22, 2026
Utility of standardized T2-weighted MRI intensity ratio for prediction of pituitary macroadenoma consistencyIshan Shah, David Gomez, David J Cote, et al.
Journal of Medicinal Chemistry|October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonistsKevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry Letters|April 3, 2012
4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulatorsHermogenes N Jimenez, Kevin G Liu, Sang-Phyo Hong, et al.
Journal of Medicinal Chemistry|April 14, 2020
Discovery and Optimization of Glucose Uptake InhibitorsKevin G Liu, Ji-In Kim, Kellen Olszewski, et al.
World Neurosurgery|July 27, 2024
Lumbar Fusions in Patients with Sickle Cell Disease: A Propensity-Matched Analysis of Postoperative ComplicationsKevin G Liu, Andy T Ton, Michael Brown, et al.
Bioorganic & Medicinal Chemistry Letters|May 13, 2009
Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Bioorganic & Medicinal Chemistry Letters|April 7, 2009
1-Sulfonylindazoles as potent and selective 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Bioorganic & Medicinal Chemistry Letters|January 21, 2009
Identification of a series of benzoxazoles as potent 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2008
A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligandsKevin G Liu, Jennifer R Lo, Thomas A Comery, et al.
Cell Chemical Biology|October 29, 2021
Inhibition of glucose transport synergizes with chemical or genetic disruption of mitochondrial metabolism and suppresses TCA cycle-deficient tumorsKellen Olszewski, Anthony Barsotti, Xiao-Jiang Feng, et al.
Journal of Neurosurgery|January 22, 2026
Utility of standardized T2-weighted MRI intensity ratio for prediction of pituitary macroadenoma consistencyIshan Shah, David Gomez, David J Cote, et al.
Journal of Medicinal Chemistry|October 12, 2010
5-Piperazinyl-3-sulfonylindazoles as potent and selective 5-hydroxytryptamine-6 antagonistsKevin G Liu, Albert J Robichaud, Ronald C Bernotas, et al.
Pageof 3